Pacific Biosciences of California, Inc. Operating Leases, Rent Expense
Pacific Biosciences of California, Inc. (PACB) reported Operating Leases, Rent Expense of $6.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-02-28
- Pacific Biosciences of California, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $1.50M, a 6.25% decline year-over-year.
- Pacific Biosciences of California, Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $1.60M, a 0.00% change year-over-year.
- Pacific Biosciences of California, Inc. operating leases, rent expense for the quarter ending 2018-06-30 was $1.50M, a 6.25% decline year-over-year.
- Pacific Biosciences of California, Inc. operating leases, rent expense for the quarter ending 2018-03-31 was $1.60M, a 0.00% change year-over-year.
- Pacific Biosciences of California, Inc. operating leases, rent expense for fiscal 2019 was $6.20M, a 0.00% change from fiscal 2018.
- Pacific Biosciences of California, Inc. operating leases, rent expense for fiscal 2018 was $6.20M, a 1.59% decline from fiscal 2017.
- Pacific Biosciences of California, Inc. operating leases, rent expense for fiscal 2017 was $6.30M, a 3050.00% increase from fiscal 2016.
- Pacific Biosciences of California, Inc. operating leases, rent expense for fiscal 2016 was $200.00K, a 81.82% decline from fiscal 2015.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $6.20M 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.10M derived: sum of 2 quarters · filed 2020-02-28 | $4.60M derived: sum of 3 quarters · filed 2020-02-28 | $6.20M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.60M 10-Q · filed 2018-11-05 | $3.10M derived: sum of 2 quarters · filed 2018-11-05 | $4.70M 10-Q · filed 2018-11-05 | $6.30M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $1.50M 10-Q · filed 2018-08-03 | $3.10M 10-Q · filed 2018-08-03 | $4.70M derived: sum of 3 quarters · filed 2020-02-28 | $6.30M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $1.60M 10-Q · filed 2018-05-02 | $3.20M derived: sum of 2 quarters · filed 2020-02-28 | $4.80M derived: sum of 3 quarters · filed 2020-02-28 | $6.40M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.20M derived: sum of 2 quarters · filed 2020-02-28 | $4.80M derived: sum of 3 quarters · filed 2020-02-28 | $6.30M 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.60M 10-Q · filed 2018-11-05 | $3.20M derived: sum of 2 quarters · filed 2018-11-05 | $4.70M 10-Q · filed 2018-11-05 | $4.85M derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $1.60M 10-Q · filed 2018-08-03 | $3.10M 10-Q · filed 2018-08-03 | $3.25M derived: sum of 3 quarters · filed 2018-08-03 | $3.30M derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | $1.60M 10-Q · filed 2017-05-05 | $1.65M derived: sum of 2 quarters · filed 2018-02-26 | $1.70M derived: sum of 3 quarters · filed 2018-02-26 | $1.75M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $100.00K derived: sum of 2 quarters · filed 2018-02-26 | $148.00K derived: sum of 3 quarters · filed 2018-02-26 | $200.00K 10-K · filed 2018-02-26 |
| 2016-09-30 | $47.00K 10-Q · filed 2017-11-02 | $95.00K derived: sum of 2 quarters · filed 2017-11-02 | $147.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $48.00K 10-Q · filed 2017-08-02 | $100.20K 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $53.00K 10-Q · filed 2017-05-05 | |||
| 2015-12-31 | $1.10M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $2.20M 10-K · filed 2017-03-06 | |||
| 2013-12-31 | $2.30M 10-K · filed 2016-03-11 | |||
| 2012-12-31 | $2.40M 10-K · filed 2015-03-12 | |||
| 2011-12-31 | $2.80M 10-K · filed 2014-03-14 | |||
| 2010-12-31 | $2.10M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |